A plain-language explainer of drug safety monitoring, why it matters, and the careers it opens for life-science graduates.
Every medicine carries some level of risk. Pharmacovigilance is how the industry and regulators keep watch after a drug reaches the market — collecting reports of side effects, analysing patterns, and acting to keep patients safe long after initial approval.
Adverse-event reports arrive from hospitals, patients and clinical studies.
Each case is reviewed, coded and checked for seriousness.
Valid cases are submitted to regulators within defined timelines.
Confirmed safety signals can update product labels or clinical guidance.
Learn the practical skills behind this topic with a job-ready BCRI program.
A plain-language explainer of Individual Case Safety Reports (ICSRs) — the building block of pharmacovigilance work.
A plain-language explainer of Clinical Data Management (CDM), why it matters in clinical trials, and the careers it opens for life-science graduates.